Sign inSubmit
Tips: “quotes” for a phrase · author:Lee · a DOI goes straight to its article

9 results for “Anticoagulant”

Set a search alert
Research ArticleOpen accessEvery word in the titleTo Optimize the Brewing Process of Leaf Tea from Hippophae Rhamnoides Linn by the Antioxidant Activity and to Explore its Anticoagulant ActivityYunwen Zhu, Limei Ran, Hongli ZhouToimprove the edible value of Hippophae RhamnoidesLinn. Leaf (HRLL), investigates the optimal brewing conditions and changespeople's brewing habits, and makes better use of resources. The effects ofdifferent parameters (brewing times, brewing time, temperature, andsolid-liquid ratio) on the brewing process of HRLL tea were optimized byresponse surface methodology with antioxidant activity as an indicator.The optimal process was as follows: The brewing … …American Journal of Biochemistry and Biotechnology, Vol. 18, Issue 4 · 14 Nov 2022 · 5,612 accessesView PDFCite
Research ArticleOpen accessEvery word in the titleStability of Neodymium(III) Complexes of 4-Hydroxycoumarins with Anticoagulant ActivityIrena Kostova, Irina NikolovaComplexes of neodymium(III) with 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one, 4-hydroxy-3-[1-(4-chlorophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one and 4-hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-1-benzopyran-2-one were synthesized by mixing of water solutions of neodymium(III) nitrate and the respective ligands, in amounts equal to metal: ligand molar ratio of 1: 3. The complexes were characterized and identified by elemental analysis, conductivity, IR and 1H NMR spectral data. DTA and TGA have been applied to confirm the compositions of … …American Journal of Pharmacology and Toxicology, Vol. 1, Issue 2 · 30 Jun 2006 · 7,554 accessesView PDFCite
Research ArticleOpen accessEvery word in the titleScreening of Bioactive Constituents from the Aerial Parts of Dictamnus dasycarpus Turcz. With Antioxidant, Immunoenhancing, and Anticoagulant PotentialJiaqi Sun, Shiyu Ji et al.The cultivation of Dictamnus dasycarpus Turcz (DdT) is expensive and difficulty associated with growing, making its root bark the only commonly used medicinal part, while other parts are discarded. Therefore, in order to improve the limited utilization of resources, the new medicinal parts were screened from polysaccharide-rich aqueous extracts. The samples were the purified polysaccharides from the aerial part on … …American Journal of Biochemistry and Biotechnology, Vol. 21, Issue 2 · 9 Oct 2025 · 2,018 accessesView PDFCite
Research ArticleOpen accessIn the keywordsAnti-β2 Glycoprotein-I Antibody in Acute Myocardial InfarctionMohammad Shojaei, Abdolreza Sotoodeh Jahromi, Hamideh Ebadat et al.Problem statement: Ischemic cardiac manifestations have been reported in a various percentage of patients with anti-phospholipid antibodies. Data concerning the relation between anti- Phospholipid (aPL) antibodies and myocardial infarction in subjects without evidence of overt autoimmune disease are conflicting. Anti-beta2 glycoprotein-I (anti-beta2-GPI) antibody is detected in various diseases like rheumatoid arthritis, systemic lupus erythematosus and anti-phospholipid antibody syndrome. The study … …American Journal of Applied Sciences, Vol. 8, Issue 8 · 18 Jul 2011 · 7,051 accessesView PDFCite
Research ArticleOpen accessIn the abstractFactors Associated with Death in Patients COVID-19 at the Epidemic Treatment Center of the Fann National University Hospital, DakarViviane Marie Pierre Cisse, Khardiata Diallo Mbaye, Ndèye Maguette Fall et al.The aim of this study was to identify the factors associated with death in patients monitored for COVID-19 at the Epidemic Treatment Center (ETC) of the Fann National University Hospital (FNUH). This was a cross-sectional, retrospective, descriptive, and analytical study of patients hospitalized for COVID-19 during the period from 1 July 2021 to 31 March 2022. Patients aged 16 years … …American Journal of Infectious Diseases, Vol. 20, Issue 2 · 4 Nov 2024 · 4,257 accessesView PDFCite
EditorialOpen accessIn the abstractCURRENT SCENARIO OF THERAPEUTICS FOR EBOLA VIRUS DISEASEML Arvinda Swamy, Madhavan P.N. Nair, Shailendra K. SaxenaCurrently various countries in Africa, including Liberia, Sierra Leone, Guinea, Nigeria, are facing disaster due to Ebola Virus Disease (EVD), which is primarily caused by Ebola virus. 2014 outbreak of Ebola associated viral haemorrhagic fever has 55-60% fatality rate. The incubation period of Ebola is below 21 days; once the appearance of symptoms starts the person will be infective. As … …American Journal of Infectious Diseases, Vol. 10, Issue 3 · 3 Sep 2014 · 7,744 accessesView PDFCite
Research ArticleOpen accessIn the abstractPlatelets, Coagulation and Cancer: Multifaceted InteractionsT. Burnouf, H. A. GoubranApproach: Literature review of the multifaceted interactions between platelets, coagulation and cancer. Results: Over the years, the links existing between cancer development, progression and occurrence of metastasis on one side and coagulation on the other have become obvious. Tumors seems to activate platelets whereas, platelets, on the other hand, through their capacity to activate and release soluble factors and microparticles, … …Current Research in Medicine, Vol. 3, Issue 2 · 30 Jul 2012 · 7,613 accessesView PDFCite
Research ArticleOpen accessIn the abstractRandomized Clinical Stroke Trials in 2009Meheroz H. RabadiProblem statement: Stroke ranks as the leading cause of serious, long-term disability and death world-wide. It is estimated direct and indirect cost of stroke for 2009 was $68.9 billion. Approach: The objective of this review was to examine the effectiveness of emerging pharmacotherapy’s in patients with acute (≤2 weeks), sub-acute (2-12 weeks) and chronic (≥12 weeks) stroke studied in Randomized … …Current Research in Medicine, Vol. 1, Issue 1 · 30 Jun 2010 · 7,243 accessesView PDFCite
Research ArticleOpen accessIn the abstractRandomized Clinical Stroke Trials In 2008Meheroz H. RabadiProblem statement: Stroke ranks as the third leading cause of death and the leading cause of serious, long-term disability; estimated direct and indirect cost of stroke for 2009 was $68.9 billion. Approach: The objective of this review was to examine the effectiveness of emerging pharmacotherapies in patients with acute (≤2 weeks), sub-acute (2-12 weeks) and chronic (≥12 weeks) stroke studied … …Current Research in Medicine, Vol. 1, Issue 1 · 30 Jun 2010 · 8,003 accessesView PDFCite